Fibromuscular Dysplasia Workup

  • Author: James A Wilson, MD, MSc, FRCPC; Chief Editor: Helmi L Lutsep, MD   more...
 
Updated: Apr 4, 2012
 

Laboratory Studies

Although usually nonproductive, routine laboratory investigations may show renal impairment (eg, with high creatinine or BUN levels).

Next

Imaging Studies

  • For a more focused analysis of imaging studies in FMD, please see Fibromuscular Dysplasia (Carotid Artery).
  • The history of stroke or transient ischemic attack in a young individual or a subarachnoid hemorrhage in a person of any age should prompt imaging of the cerebrovascular system. Further, any individual known to have FMD (eg, renal disease detected) should undergo cerebrovascular imaging to assess for craniocervical involvement and aneurysms.
  • Conventional angiography remains the criterion standard to detect FMD and its associated vascular lesions (eg, aneurysms, dissections). (See images below.)
    • FMD lesions typically show a beading pattern. With the most common subtype of FMD, medial fibroplasias, the dilated arterial segments are often larger in diameter than the original vessel. This is not the case with perimedial fibroplasias, in which the beads are up to, but not greater than, the caliber of the original vessel. On the other hand, the intimal fibroplasia and the medial hyperplasia subtypes tend to show long tubular stenoses.[23]
    • In the internal carotid arteries, these lesions are usually extracranial at the C1-2 level. Stenoses associated with arterial bifurcations, such as at the bifurcation of the common carotid, are more frequently atherosclerotic in nature. Four-vessel angiography should be performed because of the high incidence of multiple vessel involvement.
    • In 1986, Luscher et al identified 24 patients with cerebrovascular FMD and found that 17% had involvement of the vertebral arteries, 17% had brachiocephalic or subclavian involvement, and 4% had basilar artery disease.[6] Digital subtraction angiogram of the right internaDigital subtraction angiogram of the right internal carotid artery demonstrates an irregular extracranial portion that is consistent with FMD. Conventional angiogram of the left carotid artery Conventional angiogram of the left carotid artery demonstrates a 1.5-cm, long, smooth, severe stenosis of the extracranial internal carotid artery. Note that the artery is not completely occluded and a thin continuous string of contrast is present along the length of the stenosis. This smooth tubular stenosis is suggestive of the intimal fibroplasia form of FMD but can be observed with any of the subtypes. Cerebral angiogram of the left carotid artery terrCerebral angiogram of the left carotid artery territory demonstrates a long, irregular stenosis with a string-of-beads appearance along the entire extracranial length of the internal carotid artery (ICA). This is consistent with the most common medial dysplasia form of fibromuscular dysplasia. Also note similar involvement of the first 3 cm of the external carotid artery (ECA). Such extensive ICA involvement, as well as ECA involvement, is atypical. Note sparing of the carotid bulb. Lateral view of a right carotid angiogram demonstrLateral view of a right carotid angiogram demonstrates multiple stenoses of FMD of the internal carotid artery. The string of beads appearance is suggestive of the medial dysplasia form of FMD. Anteroposterior view of a right carotid angiogram Anteroposterior view of a right carotid angiogram demonstrates FMD of the extracranial portion of the right internal carotid artery. Angiogram of the descending aorta demonstrates theAngiogram of the descending aorta demonstrates the stenoses of FMD in the renal arteries bilaterally. Angiogram of the right vertebral artery demonstratAngiogram of the right vertebral artery demonstrating irregular stenoses of fibromuscular dysplasia at the level of C2-3.
  • Conventional cerebrovascular ultrasonography is unlikely to depict the carotid lesions of FMD because they are typically sufficiently distal to the carotid bifurcation so as to avoid detection by standard carotid duplex investigation.
    • Submandibular insonation with a transcranial Doppler probe directed at the high cervical segments can be used to investigate the distal cervical artery and has moderate sensitivity for detecting FMD.
    • Doppler scanning of the vertebrobasilar system may reveal reversal of flow (including subclavian steal), but it is not in any way sensitive or specific for FMD.
  • To the authors' knowledge, no large studies have been conducted to assess the sensitivity or specificity of CT angiography (CTA), time-of-flight (TOF) magnetic resonance angiography (MRA), or contrast-enhanced MRA (CE MRA) in the diagnosis of craniocervical FMD. However, these modalities, especially CTA and CE MRA, can show surprising vascular detail and may be sufficiently sensitive for the confident detection of FMD. Due to the risk of conventional angiography, there is certainly a need to identify comparably sensitive noninvasive imaging techniques. Fortunately, we have some clues from the renal literature that the above noninvasive techniques could be comparable.
    • CTA is continuously improving in resolution and may be used to detect the stenosis associated with FMD, but only recent-generation CTA equipment reliably shows sufficient detail to identify the classic string of beads pattern of most FMD cases. de Monye advocates the use of CTA as a noninvasive modality to diagnose FMD, albeit with only a series of 2 patients.[24] Regarding FMD of the renal arteries, the sensitivity of CTA has been compared directly with conventional angiography.[25] In their series of 21 patients with 40 total lesions identified on conventional angiography, all lesions were identified using several modalities of CTA (multiplanar reformatted images, maximum intensity projections, and shaded-surface display). Suspecting that CTA of the carotid arteries shares similar sensitivity to conventional angiography in identifying craniocervical FMD would be reasonable.
    • Findings on TOF MRA often suggest vessel stenoses, but this study has insufficient resolution to demonstrate a string-of-beads pattern suggestive of FMD.
    • Contrast-enhanced MRA will likely perform better than TOF MRA, but this has not yet been studied in detail regarding craniocervical FMD. However, similar to CTA, the renal literature has looked at FMD of the renal arteries using CE MRA. In a series of 25 patients, Willoteaux found the sensitivity and specificity of CE MRA in renal FMD to be 97% and 93% respectively.[26] They found 68% sensitivity in diagnosing stenosis, 95% in identifying the string of pearls, and 100% sensitivity in identifying an aneurysm. Thus, although CE MRA in craniocervical FMD has not specifically been assessed, it is likely that this modality is reasonably sensitive as compared with the more invasive criterion standard.
  • Conventional CT scanning and MRI may be useful in finding ischemic strokes caused by arterial dissection or the FMD lesions themselves.
    • These modalities can also be useful in detecting subarachnoid hemorrhage.
    • CTA and MRA can often detect aneurysms greater than about 0.3 cm.
Previous
Next

Other Tests

No other tests are specifically indicated in the workup of FMD.

Previous
Next

Procedures

In general, procedures are not indicated in the diagnosis of FMD.

Previous
Next

Histologic Findings

Pathologically, FMD is a nonatherosclerotic noninflammatory narrowing of medium-sized arteries characterized by fibrodysplastic changes. In 1979, Bragin and Cherkasov described the ultrastructural changes that occur in FMD as smooth muscle assuming fibroblastic characteristics.[27] FMD has been classified according to the arterial wall layer that is predominantly affected.[28]

The pathologic classification of FMD is as follows:[28, 12, 29]

  • Intimal fibroplasia
    • This accounts for fewer than 10% of all cases of renal FMD.
    • Collagen deposition occurs in the intima of the vessels.
    • Internal elastic lamina may be disrupted.
    • The lumen may be concentrically narrowed in a relatively short region, causing a ringlike stenosis on angiography, or it may be narrowed over a longer region as a smooth tubular stenosis.
  • Medial fibroplasia (3 subtypes)
    • Medial dysplasia
      • This accounts for 80% of renal cases and most carotid cases.
      • Regions of thick, fibrodysplastic, collagenized tunica media alternate with regions of thinned media.
      • The result is the classic string-of-beads appearance on angiography.
    • Perimedial fibroplasia
      • This accounts for 10-15% of all renal cases of FMD.
      • Patchy collagen deposition is observed in the outer media without disruption of the external elastic lamina.
      • This subtype can also result in the string-of-beads appearance on angiography, but the beads are not dilated to a larger diameter than that of the original vessel.
    • Medial hyperplasia
      • This accounts for 1-2% of all renal cases of FMD.
      • True smooth muscle concentric hyperplasia without fibrotic changes is noted.
      • The result is a smooth stenosis on radiographic study.
  • Adventitial fibroplasia
    • This form results in fewer than 1% of all renal cases of FMD.
    • Dense collagen replaces the normally loose connective tissue of the adventitia.

The percentage occurrence of each type of FMD is largely based on findings from large renal studies and may not reflect the distribution of FMD types in carotid disease. In fact, the medial dysplasia type may be even more predominant when carotid FMD is considered alone.

Previous
Next

Staging

No formal staging system exists for FMD, although 4-vessel angiography of the cerebrovasculature is used to identify the extent of the craniocervical disease and the presence of comorbid dissections and aneurysms.

Previous
 
 
Contributor Information and Disclosures
Author

James A Wilson, MD, MSc, FRCPC  Neurologist and Clinical Neurophysiologist, Oconee Neurology Services

James A Wilson, MD, MSc, FRCPC, is a member of the following medical societies: American Academy of Neurology and Ontario Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

Richard L Hughes, MD  Professor of Neurology, University of Colorado at Denver School of Medicine; Chief, Division of Neurology, Denver Health Medical Center

Richard L Hughes, MD is a member of the following medical societies: American Academy of Neurology, American Heart Association, American Medical Association, and North American Neuro-Ophthalmology Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Jeffrey L Saver, MD, FAHA, FAAN  Professor of Neurology, Director, UCLA Stroke Center, University of California, Los Angeles, David Geffen School of Medicine

Jeffrey L Saver, MD, FAHA, FAAN is a member of the following medical societies: American Academy of Neurology, American Heart Association, American Neurological Association, and National Stroke Association

Disclosure: University of California The University of California Regents receive funds for consulting services on clinical trial design provided to Telecris, Ev3, and CoAxia. Consulting

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Howard S Kirshner, MD  Professor of Neurology, Psychiatry and Hearing and Speech Sciences, Vice Chairman, Department of Neurology, Vanderbilt University School of Medicine; Director, Vanderbilt Stroke Center; Program Director, Stroke Service, Vanderbilt Stallworth Rehabilitation Hospital; Consulting Staff, Department of Neurology, Nashville Veterans Affairs Medical Center

Howard S Kirshner, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Neurology, American Heart Association, American Medical Association, American Neurological Association, American Society of Neurorehabilitation, National Stroke Association, Phi Beta Kappa, and Tennessee Medical Association

Disclosure: Nothing to disclose.

Selim R Benbadis, MD  Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, Tampa General Hospital, University of South Florida College of Medicine

Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association

Disclosure: UCB Pharma Honoraria Speaking, consulting; Lundbeck Honoraria Speaking, consulting; Cyberonics Honoraria Speaking, consulting; Glaxo Smith Kline Honoraria Speaking, consulting; Pfizer Honoraria Speaking, consulting; Sleepmed/DigiTrace Honoraria Speaking, consulting

Chief Editor

Helmi L Lutsep, MD  Professor and Vice Chair, Department of Neurology, Oregon Health and Science University School of Medicine; Associate Director, Oregon Stroke Center

Helmi L Lutsep, MD is a member of the following medical societies: American Academy of Neurology and American Stroke Association

Disclosure: Co-Axia Consulting fee Review panel membership; AGA Medical Consulting fee Review panel membership; Concentric Medical Consulting fee Review panel membership

References
  1. Luscher TF, Lie JT, Stanson AW, et al. Arterial fibromuscular dysplasia. Mayo Clin Proc. Oct 1987;62(10):931-52. [Medline].

  2. Gray GH, Young JR, Olin JW. Miscellaneous arterial diseases. In: Young JR, Olin JW, Bartholomew J, eds. Peripheral Vascular Diseases. 2nd ed. St Louis: Mosby-Yearbook; 1996:425-40.

  3. James TN. Morphologic characteristics and functional significance of focal fibromuscular dysplasia of small coronary arteries. Am J Cardiol. Apr 3 1990;65(14):12G-22G. [Medline].

  4. Campman SC, Holmes JF, Sokolove PE, et al. Pulmonary arterial fibromuscular dysplasia: a rare cause of fulminant lunghemorrhage. Am J Forensic Med Pathol. Mar 2000;21(1):69-73. [Medline].

  5. Maresi E, Becchina G, Ottoveggio G, et al. Arrhythmic sudden cardiac death in a 3-year-old child with intimal fibroplasia of coronary arteries, aorta, and its branches. Cardiovasc Pathol. Jan-Feb 2001;10(1):43-8. [Medline].

  6. Luscher TF, Keller HM, Imhof HG, et al. Fibromuscular hyperplasia: extension of the disease and therapeutic outcome. Results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia. Nephron. 1986;44 Suppl 1:109-14. [Medline].

  7. Hill LD, Antonius JI. Arterial dysplasia: an important surgical lesion. Arch Surg. Apr 1965;90:585-95. [Medline].

  8. Heffelfinger MJ, Holley KE, Havrison EG. Arterial fibromuscular dysplasia studied at autopsy [abstract]. Am J Clin Pathol. 1970;54:274.

  9. Schievink WI, Bjornsson J. Fibromuscular dysplasia of the internal carotid artery: a clinicopathological study. Clin Neuropathol. Jan-Feb 1996;15(1):2-6. [Medline].

  10. Mettinger KL, Ericson K. Fibromuscular dysplasia and the brain. I. Observations on angiographic, clinical and genetic characteristics. Stroke. Jan-Feb 1982;13(1):46-52. [Medline].

  11. Cloft HJ, Kallmes DF, Kallmes MH, et al. Prevalence of cerebral aneurysms in patients with fibromuscular dysplasia:a reassessment. J Neurosurg. Mar 1998;88(3):436-40. [Medline].

  12. Stanley JC, Gewertz BL, Bove EL, et al. Arterial fibrodysplasia. Histopathologic character and current etiologic concepts. Arch Surg. May 1975;110(5):561-6. [Medline].

  13. Arunodaya GR, Vani S, Shankar SK, et al. Fibromuscular dysplasia with dissection of basilar artery presenting as "locked-in-syndrome". Neurology. Jun 1997;48(6):1605-8. [Medline].

  14. Eachempati SR, Sebastian MW, Reed RL 2nd. Posttraumatic bilateral carotid artery and right vertebral artery dissections in a patient with fibromuscular dysplasia: case report and review of the literature. J Trauma. Feb 1998;44(2):406-9. [Medline].

  15. Rushton AR. The genetics of fibromuscular dysplasia. Arch Intern Med. Feb 1980;140(2):233-6. [Medline].

  16. Bigazzi R, Bianchi S, Quilici N, et al. Bilateral fibromuscular dysplasia in identical twins. Am J Kidney Dis. Dec 1998;32(6):E4. [Medline].

  17. Tromp G, Wu Y, Prockop DJ, et al. Sequencing of cDNA from 50 unrelated patients reveals that mutations inthe triple-helical domain of type III procollagen are an infrequent causeof aortic aneurysms. J Clin Invest. Jun 1993;91(6):2539-45. [Medline].

  18. McKusick VA. Heritable Disorders of Connective Tissue. 4th ed. St Louis: Mosby-Yearbook; 1972:382-6.

  19. Schievink WI, Meyer FB, Parisi JE, Wijdicks EF. Fibromuscular dysplasia of the internal carotid artery associated with alpha1-antitrypsin deficiency. Neurosurgery. Aug 1998;43(2):229-33; discussion 233-4. [Medline].

  20. de Bray JM, Marc G, Pautot V, Vielle B, Pasco A, Lhoste P. Fibromuscular dysplasia may herald symptomatic recurrence of cervical artery dissection. Cerebrovasc Dis. 2007;23(5-6):448-52. [Medline].

  21. Lee EK, Hecht ST, Lie JT. Multiple intracranial and systemic aneurysms associated withinfantile-onset arterial fibromuscular dysplasia. Neurology. Mar 1998;50(3):828-9. [Medline].

  22. Kim SD, Park JO, Kim SH, Lee YH, Lim DJ, Park JY. Spontaneous thoracic spinal subdural hematoma associated with fibromuscular dysplasia. J Neurosurg Spine. May 2008;8(5):478-81. [Medline].

  23. Mettinger KL. Fibromuscular dysplasia and the brain. II. Current concept of the disease. Stroke. Jan-Feb 1982;13(1):53-8. [Medline].

  24. de Monyé C, Dippel DW, Dijkshoorn ML, Tanghe HL, van der Lugt A. MDCT detection of fibromuscular dysplasia of the internal carotid artery. AJR Am J Roentgenol. April 2007;188(4):W367-9. [Medline].

  25. Sabharwal R, Vladica P, Coleman P. Multidetector spiral CT renal angiography in the diagnosis of renal artery fibromuscular dysplasia. Eur J Radiol. March 2007;61(3):520-7. [Medline].

  26. Willoteaux S, Faivre-Pierret M, Moranne O, Lions C, Bruzzi J, Finot M, et al. Fibromuscular dysplasia of the main renal arteries: comparison of contrast-enhanced MR angiography with digital subtraction angiography. Radiology. December 2006;241(3):922-9. [Medline].

  27. Bragin MA, Cherkasov AP. [Morphogenesis of fibromuscular dysplasia of the renal arteries (anultrastructural study)]. Arkh Patol. 1979;41(2):46-52. [Medline].

  28. Harrison EG Jr, McCormack LJ. Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc. Mar 1971;46(3):161-7. [Medline].

  29. Begelman SM, Olin JW. Fibromuscular dysplasia. Curr Opin Rheumatol. Jan 2000;12(1):41-7. [Medline].

  30. Kimura H, Hosoda K, Hara Y, Kohmura E. A very unusual case of fibromuscular dysplasia with multiple aneurysms of the vertebral artery and posterior inferior cerebellar artery. J Neurosurg. Dec 2008;109(6):1108-12. [Medline].

  31. Reiher L, Pfeiffer T, Sandmann W. Long-term results after surgical reconstruction for renal artery fibromuscular dysplasia. Eur J Vasc Endovasc Surg. Dec 2000;20(6):556-9. [Medline].

  32. Van Damme H, Sakalihasan N, Limet R. Fibromuscular dysplasia of the internal carotid artery. Personal experience with 13 cases and literature review. Acta Chir Belg. Aug 1999;99(4):163-8. [Medline].

  33. Chiche L, Bahnini A, Koskas F, Kieffer E. Occlusive fibromuscular disease of arteries supplying the brain: results of surgical treatment. Ann Vasc Surg. Sep 1997;11(5):496-504. [Medline].

  34. Collins GJ Jr, Rich NM, Clagett GP, et al. Fibromuscular dysplasia of the internal carotid arteries. Clinical experience and follow-up. Ann Surg. Jul 1981;194(1):89-96. [Medline].

  35. Finsterer J, Strassegger J, Haymerle A, Hagmüller G. Bilateral stenting of symptomatic and asymptomatic internal carotid artery stenosis due to fibromuscular dysplasia. J Neurol Neurosurg Psychiatry. Nov 2000;69(5):683-6. [Medline].

  36. Leadbetter WF, Burkland CD. Hypertension in unilateral renal disease. J Urol. 1938;39:611-26.

  37. Leary MC, Finley A, Caplan LR. Cerebrovascular Complications of Fibromuscular Dysplasia. Curr Treat Options Cardiovasc Med. Jun 2004;6(3):237-248. [Medline].

  38. Olin JW. Recognizing and managing fibromuscular dysplasia. Cleve Clin J Med. Apr 2007;74(4):273-4, 277-82. [Medline].

  39. Palubinskas AJ, Ripley HR. Fibromuscular hyperplasia in extrarenal arteries. Radiology. 1946;82:451-55.

  40. Vuong PN, Desoutter P, Mickley V. Fibromuscular dysplasia of the renal artery responsible for renovascular hypertension: a histological presentation based on a series of 102 patients. Vasa. Feb 2004;33(1):13-8. [Medline].

Previous
Next
 
Digital subtraction angiogram of the right internal carotid artery demonstrates an irregular extracranial portion that is consistent with FMD.
Conventional angiogram of the left carotid artery demonstrates a 1.5-cm, long, smooth, severe stenosis of the extracranial internal carotid artery. Note that the artery is not completely occluded and a thin continuous string of contrast is present along the length of the stenosis. This smooth tubular stenosis is suggestive of the intimal fibroplasia form of FMD but can be observed with any of the subtypes.
Cerebral angiogram of the left carotid artery territory demonstrates a long, irregular stenosis with a string-of-beads appearance along the entire extracranial length of the internal carotid artery (ICA). This is consistent with the most common medial dysplasia form of fibromuscular dysplasia. Also note similar involvement of the first 3 cm of the external carotid artery (ECA). Such extensive ICA involvement, as well as ECA involvement, is atypical. Note sparing of the carotid bulb.
Lateral view of a right carotid angiogram demonstrates multiple stenoses of FMD of the internal carotid artery. The string of beads appearance is suggestive of the medial dysplasia form of FMD.
Anteroposterior view of a right carotid angiogram demonstrates FMD of the extracranial portion of the right internal carotid artery.
Angiogram of the descending aorta demonstrates the stenoses of FMD in the renal arteries bilaterally.
Angiogram of the right vertebral artery demonstrating irregular stenoses of fibromuscular dysplasia at the level of C2-3.
Illustration of the operative approach of graduated dilatation of the internal carotid artery (ICA). The common carotid and external carotid arteries are cross-clamped, and the superior thyroid artery is clipped while the ICA is isolated, opened, and dilated with progressively larger dilators. This technique has been shown to be successful in the management of medically refractive FMD stenoses.
Illustration depicts the intraluminal appearance of graduated dilatation of the stenoses of FMD. The dilator is passed into the vessel and opens the bandlike narrowings.
Illustration depicts the locations of FMD lesions, which differentiate regions with typical and atypical angiographic appearances of this disease.
Digital subtraction angiography of the left internal carotid artery distribution demonstrates a large 1.5-cm-diameter aneurysm of the right anterior communicating artery. Aneurysms may be associated with systemic vasculopathies such as FMD.
Small infarct in woman with fibromuscular dysplasia from dissected vertebral artery. An incidental aneurysm, or ovoid diverticula, is noted in the supraclinoid left internal carotid artery.
Small infarct in woman with fibromuscular dysplasia from dissected vertebral artery. An incidental aneurysm, or ovoid diverticula, is noted in the supraclinoid left internal carotid artery. Dissected vertebral artery.
Small infarct in woman with fibromuscular dysplasia from dissected vertebral artery. An incidental aneurysm, or ovoid diverticula, is noted in the supraclinoid left internal carotid artery. Internal carotid angiogram.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.